1. Home
  2. NHWK

NHWK

NightHawk Biosciences Inc.

Logo NightHawk Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

0

NightHawk Biosciences Inc is a commercial-stage company with a fully integrated ecosystem to accelerate the discovery and development of novel therapies that arm the immune system. By leveraging its proprietary platforms, the company is advancing its first-in-class product portfolio with a focus on cancer and inflammatory and infectious diseases. Its current pipeline has categories: Oncology, immunology and molecular biology.

Founded: 2008 Country:
United States
United States
Employees: N/A City: MORRISVILLE
Market Cap: 9.9M IPO Year: 2013
Target Price: N/A AVG Volume (30 days): 154.1K
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.00 EPS Growth: N/A
52 Week Low/High: $0.26 - $1.16 Next Earning Date: 04-01-2024
Revenue: $2,226,721 Revenue Growth: 138.06%
Revenue Growth (this year): -21.7% Revenue Growth (next year): 320.41%

Share on Social Networks: